Utidelone Antibody Drug Conjugate(Beijing Biostar Pharmaceuticals Co Ltd)

优替德隆抗体偶联药物（北京华昊中天生物医药股份有限公司）

Report date: 2025/11/19 10:01:03

Base Information

Drug NameUtidelone Antibody Drug Conjugate(Beijing Biostar Pharmaceuticals Co Ltd)
Drug Alias Name优替德隆ADC（北京华昊中天生物医药股份有限公司）Utidelone ADC(Beijing Biostar Pharmaceuticals Co Ltd)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Biostar Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Biostar Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A